These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34995829)

  • 21. Effect of thin-split encephalomyosynangiosis on transient neurological events in revascularization surgery for pediatric patients with moyamoya disease.
    Ishii K; Kanamori F; Araki Y; Uda K; Yokoyama K; Mamiya T; Takayanagi K; Goto S; Nishihori M; Izumi T; Saito R
    J Neurosurg Pediatr; 2024 Jan; 33(1):29-34. PubMed ID: 37856402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk Factors for Cerebral Hyperperfusion Syndrome After Combined Revascularization in Adult Patients with Moyamoya Disease.
    Xu D; Guo J; Zheng B; Wu Q; Gareev I; Beylerli O; Beilerli A; Shi H
    Curr Neurovasc Res; 2024; 20(5):623-629. PubMed ID: 38321905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.
    Liu XJ; Zhang D; Wang S; Zhao YL; Teo M; Wang R; Cao Y; Ye X; Kang S; Zhao JZ
    J Neurosurg; 2015 Feb; 122(2):392-9. PubMed ID: 25423267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence and Risk Factors of the Watershed Shift Phenomenon after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis for Adult Moyamoya Disease.
    Tashiro R; Fujimura M; Kameyama M; Mugikura S; Endo H; Takeuchi Y; Tomata Y; Niizuma K; Tominaga T
    Cerebrovasc Dis; 2019; 47(3-4):178-187. PubMed ID: 31121577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preservation of the Arachnoid Membrane During Encephaloduroarteriosynangiosis Reduces Postoperative Complications without Undermining the Surgical Outcome in Pediatric Moyamoya Disease.
    Byun YH; Phi JH; Lee JY; Ha EJ; Kim KH; Yang J; Kim HS; Ryu SK; Choi JW; Cho BK; Kim SK
    World Neurosurg; 2019 Oct; 130():e406-e416. PubMed ID: 31233923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcomes after revascularization for pediatric moyamoya disease and syndrome: A single-center series.
    Morshed RA; Abla AA; Murph D; Dao JM; Winkler EA; Burkhardt JK; Colao K; Hetts SW; Fullerton HJ; Lawton MT; Gupta N; Fox CK
    J Clin Neurosci; 2020 Sep; 79():137-143. PubMed ID: 33070883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of Factors Related to Cerebral Infarction after Direct Bypass Surgery in Adults with Moyamoya Disease.
    Qian Y; Huang B; Hu Z; Wang J; Zhao P; Li X
    Cerebrovasc Dis; 2020; 49(1):55-61. PubMed ID: 31955156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uneven cerebral hemodynamic change as a cause of neurological deterioration in the acute stage after direct revascularization for moyamoya disease: cerebral hyperperfusion and remote ischemia caused by the 'watershed shift'.
    Tu XK; Fujimura M; Rashad S; Mugikura S; Sakata H; Niizuma K; Tominaga T
    Neurosurg Rev; 2017 Jul; 40(3):507-512. PubMed ID: 28357585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transient neurological events in childhood moyamoya disease.
    Chiba K; Aihara Y; Fukui A; Yamaguchi K; Kawashima A; Okada Y; Kawamata T
    J Neurosurg Pediatr; 2023 Jan; 31(1):78-86. PubMed ID: 36334284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for postoperative ischemic complications in pediatric moyamoya disease.
    Deng X; Ge P; Wang R; Zhang D; Zhao J; Zhang Y
    BMC Neurol; 2021 Jun; 21(1):229. PubMed ID: 34157993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors and clinical features of transient neurological events after combined bypass revascularization for moyamoya disease.
    Lu J; Zhao Y; Ma L; Chen Y; Li M; Chen X; Ye X; Wang R; Zhao Y
    Clin Neurol Neurosurg; 2019 Nov; 186():105505. PubMed ID: 31622898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk Factors for Specific Postoperative Ischemic Complications in Patients with Moyamoya Disease: A Single-Center Retrospective Study.
    Zhu H; Zhang Q; Li W; Wang P; Zhang Q; Zhang D; Zhang Y
    Turk Neurosurg; 2024; 34(2):289-298. PubMed ID: 38497182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of Quantitative Cerebral Blood Flow Measurement in the Acute Stage after Revascularization Surgery for Adult Moyamoya Disease: Implication for the Pathological Threshold of Local Cerebral Hyperperfusion.
    Kameyama M; Fujimura M; Tashiro R; Sato K; Endo H; Niizuma K; Mugikura S; Tominaga T
    Cerebrovasc Dis; 2019; 48(3-6):217-225. PubMed ID: 31812964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Surgical Approaches to Pediatric Moyamoya Disease].
    Fujimura M; Ito M
    No Shinkei Geka; 2022 Jul; 50(4):819-825. PubMed ID: 35946371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of Combined Revascularization Surgery for Moyamoya Disease without Preoperative Cerebral Angiography.
    Okuyama T; Kawabori M; Ito M; Sugiyama T; Kazumata K; Fujimura M
    World Neurosurg; 2022 Sep; 165():e446-e451. PubMed ID: 35750140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of antiplatelet therapy during the perioperative period of revascularization surgery for moyamoya disease patients with ischemic onset.
    Nakamura A; Takasu S; Seki Y; Saito R
    Nagoya J Med Sci; 2024 Feb; 86(1):82-90. PubMed ID: 38505724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of Risk Factors for Epilepsy after Combined Re-Vascularization in Adult Patients with Moyamoya Disease.
    Liu E; Jin L; Tao W; Tan X; Liu C; Zhou S; Huang S; Qian X; Zhao J; Li X; Yang S
    Neurol India; 2023; 71(3):471-475. PubMed ID: 37322743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Encephaloduroarteriosynangiosis with Dural Inversion for Moyamoya Disease in a Pediatric and Adult Population-a Single-Center 20-Year Experience.
    Goren O; Hendrix P; Peled A; Kimchi G; Zauberman J; Griessenauer C; Feldman Z
    World Neurosurg; 2021 May; 149():e16-e21. PubMed ID: 33647488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wound healing complications after revascularization for moyamoya vasculopathy with reference to different skin incisions.
    Acker G; Schlinkmann N; Fekonja L; Grünwald L; Hardt J; Czabanka M; Vajkoczy P
    Neurosurg Focus; 2019 Feb; 46(2):E12. PubMed ID: 30717062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Implications of the "Brush Sign" in Susceptibility-Weighted Imaging for Moyamoya Disease.
    Lu J; Zhao Y; Li M; Ma L; Chen Y; Wang R; Ye X; Wang H; Chen X; Zhao Y
    Cerebrovasc Dis; 2021; 50(2):147-155. PubMed ID: 33556948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.